(Q51487290)

English

Effectiveness of long-term aripiprazole therapy in patients with acutely relapsing or chronic, stable schizophrenia: a 52-week, open-label comparison with olanzapine.

scientific article published on 21 October 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17058105

Effectiveness of long-term aripiprazole therapy in patients with acutely relapsing or chronic, stable schizophrenia: a 52-week, open-label comparison with olanzapine. (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17058105

0 references

0 references

author name string

Wlodzimierz K Chrzanowski

1

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17058105

Ronald N Marcus

2

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17058105

Anne Torbeyns

3

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17058105

Margaretta Nyilas

4

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17058105

Robert D McQuade

5

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17058105

publication date

21 October 2006

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17058105

number of pages

8

1 reference

based on heuristic

inferred from page(s)

Psychopharmacology

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17058105

189

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17058105

2

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17058105

259-266

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17058105

https://scigraph.springernature.com/pub.10.1007/s00213-006-0564-3

0 references

Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology

1 reference

https://api.crossref.org/works/10.1007%2FS00213-006-0564-3

21 January 2018

A comparison of weight change during treatment with olanzapine or aripiprazole: results from a randomized, double-blind study

1 reference

https://pubmed.ncbi.nlm.nih.gov/17058105

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Aripiprazole for the prevention of relapse in stabilized patients with chronic schizophrenia: a placebo-controlled 26-week study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17058105

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and safety of aripiprazole vs. haloperidol for long-term maintenance treatment following acute relapse of schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/17058105

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relapse prevention in schizophrenia with new-generation antipsychotics: a systematic review and exploratory meta-analysis of randomized, controlled trials.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17058105

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Aripiprazole, an antipsychotic with a novel mechanism of action, and risperidone vs placebo in patients with schizophrenia and schizoaffective disorder

1 reference

https://pubmed.ncbi.nlm.nih.gov/17058105

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Which side effects really matter? Screening for common and distressing side effects of antipsychotic medications.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17058105

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Practice guideline for the treatment of patients with schizophrenia. American Psychiatric Association

1 reference

https://pubmed.ncbi.nlm.nih.gov/17058105

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and safety of aripiprazole and haloperidol versus placebo in patients with schizophrenia and schizoaffective disorder.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17058105

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Texas Medication Algorithm Project Antipsychotic Algorithm for Schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/17058105

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antipsychotic drugs and relapse prevention

1 reference

https://pubmed.ncbi.nlm.nih.gov/17058105

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Texas Medication Algorithm Project antipsychotic algorithm for schizophrenia: 2003 update

1 reference

https://pubmed.ncbi.nlm.nih.gov/17058105

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00213-006-0564-3

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17058105

release_6r4s4nkagjcard7lh4a5g3ivyy

1 reference

https://api.fatcat.wiki/v0/release/6r4s4nkagjcard7lh4a5g3ivyy

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 April 2018

http://europepmc.org/abstract/MED/17058105

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51487290&oldid=1843190606"